AU2003227073A1 - Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound - Google Patents

Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound

Info

Publication number
AU2003227073A1
AU2003227073A1 AU2003227073A AU2003227073A AU2003227073A1 AU 2003227073 A1 AU2003227073 A1 AU 2003227073A1 AU 2003227073 A AU2003227073 A AU 2003227073A AU 2003227073 A AU2003227073 A AU 2003227073A AU 2003227073 A1 AU2003227073 A1 AU 2003227073A1
Authority
AU
Australia
Prior art keywords
adsorption
production
pharmaceutical preparation
aluminum compound
poorly soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227073A
Other languages
English (en)
Other versions
AU2003227073A8 (en
Inventor
Gottfried Himmler
Hans Loibner
Erich Wasserbauer
Gunter Waxenecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Original Assignee
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH filed Critical Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-GmbH
Publication of AU2003227073A1 publication Critical patent/AU2003227073A1/en
Publication of AU2003227073A8 publication Critical patent/AU2003227073A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003227073A 2002-03-20 2003-03-20 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound Abandoned AU2003227073A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ATA427/2002 2002-03-20
AT4272002 2002-03-20
PCT/AT2003/000078 WO2003077943A2 (de) 2002-03-20 2003-03-20 Verfahren zur herstellung einer pharmazeutischen präparation durch adsorption an eine schwerlösliche aluminiumverbindung

Publications (2)

Publication Number Publication Date
AU2003227073A1 true AU2003227073A1 (en) 2003-09-29
AU2003227073A8 AU2003227073A8 (en) 2003-09-29

Family

ID=27809065

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227073A Abandoned AU2003227073A1 (en) 2002-03-20 2003-03-20 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound

Country Status (2)

Country Link
AU (1) AU2003227073A1 (de)
WO (1) WO2003077943A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB960642A (en) * 1961-04-06 1964-06-10 Pfizer & Co C Measles vaccine
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
US6274143B1 (en) * 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10

Also Published As

Publication number Publication date
WO2003077943A3 (de) 2004-01-15
WO2003077943A2 (de) 2003-09-25
AU2003227073A8 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
AU2003234790A1 (en) Process for producing mevalonic acid
AU2004208606A1 (en) Process for producing coated preparation
IL175860A0 (en) Method for the production of a solid, orally applicable pharmaceutical composition
AU2003281260A1 (en) A method for optoelectronically inspecting pharmaceutical articles
AU2003263574A1 (en) A process for the preparation of phenylcarbamates
AU2003261774A1 (en) PROCESS FOR PRODUCING L-Alpha-METHYLCYSTEINE DERIVATIVE
AU2003281181A1 (en) Process for producing coated preparation
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
AU2003280338A1 (en) Process for producing vitamin c
AU2002349594A1 (en) Method for producing carbonyl compounds
AU2003259910A1 (en) Process for coating a pharmaceutical particle
AU2003296868A1 (en) A process for the preparation of free standing membranes
AU2003249995A1 (en) Method for the production of easily polymerizable compounds
AU2003218704A1 (en) Process for preparing 2-aminoindan derivatives
AU2003236804A1 (en) Method for the biotechnological production of xylitol
AU2003284758A1 (en) Method for preparing oltipraz
AU2003274518A1 (en) A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
AU2003275009A1 (en) Methods for manufacturing polysaccharide derivatives
AU2003253326A1 (en) Method for the production of phenylalanine derivatives
AU2003227073A1 (en) Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound
AU2003212351A1 (en) A process for the preparation of cephalosporan acid derivatives from cephalosporin c
AU2003284546A1 (en) Process for producing carbapenem compound for oral administration
AU2003260942A1 (en) A process for the preparation of oxindole derivatives
AU2003249964A1 (en) A process for the preparation of 2-acetoxymethyl-4 halo-but-1-yl acetates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase